Skeletal Muscle Atrophy
Skeletal muscle atrophy, also known as muscle wasting, affects over 60 million people in the US alone. Its causes include aging, immobility due to illness or injury, critical illness, diabetes, low testosterone, cancer, heart failure, COPD, stroke, renal failure, cirrhosis, Alzheimer disease, rheumatoid arthritis, ALS, spinal cord injury, HIV/AIDS, malnutrition, and medicines such as cancer chemotherapy and prednisone.
In addition to being very common, skeletal muscle atrophy has serious consequences including loss of strength and endurance, reduced quality of life, falls and fractures, loss of independent living, delayed recovery from acute illness and injury, and increased mortality in many chronic diseases.
Despite its prevalence and severity, skeletal muscle atrophy is difficult to prevent and lacks an effective treatment. To address these problems, Emmyon is discovering and developing nutritional approaches to help prevent muscle atrophy, as well as pharmaceutical compounds to treat muscle atrophy.